Mengxiong Sun
Papers
1
Total Citations
2
H-Index
1
About
Mengxiong Sun is a pioneering researcher at the intersection of biomedical engineering and oncology, with a primary focus on developing advanced microrobotic systems for targeted cancer therapy. His most notable contribution lies in the design of magnetically driven hydrogel microrobots, which represent a groundbreaking approach to drug delivery for osteosarcoma treatment. In his highly cited 2024 work, Sun introduced a novel active targeting strategy that leverages magnetic actuation to enhance the therapeutic efficacy of anlotinib, a potent anticancer agent. This innovation directly addresses the longstanding challenges of osteosarcoma—namely, its complex genetic landscape and lack of specific membrane receptors that have historically limited targeted therapies. By engineering biocompatible hydrogel microrobots that can be precisely navigated to tumor sites via external magnetic fields, Sun has opened new avenues for minimally invasive, highly localized treatment. Although his work is still in its early stages, with 2 citations to date, the conceptual and methodological advances in his research have already captured significant attention, positioning him as an emerging leader in the field of medical microrobotics and nanomedicine.
Research Focus
Key Achievements
Top Papers
- 1